Evidence map›Paper›PMID 34969430›Full record

ArticleThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease2022

TB prevalence in Zimbabwe: a national cross-sectional survey, 2014.

M Chipinduro, C Timire, J Chirenda, R Matambo, E Munemo, B Makamure, A F Nhidza, W Tinago, V Chikwasha, M Ngwenya and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

M ChipinduroDepartment of Pathology, Faculty of Medicine and Health Sciences (FMHS), Midlands State University, Gweru, Zimbabwe.
C TimireInternational Union Against Tuberculosis and Lung Disease (The Union), Paris, France, National TB Control Programme, Ministry of Health and Child Care, Harare, Zimbabwe.
J ChirendaDepartment of Community Medicine, FMHS, University of Zimbabwe, Harare, Zimbabwe.
R MatamboBiomedical Research and Training Institute, Harare, Zimbabwe.
E MunemoNational Microbiology Reference Laboratory, Harare, Zimbabwe.
B MakamureBiomedical Research and Training Institute, Harare, Zimbabwe.
A F NhidzaBiomedical Research and Training Institute, Harare, Zimbabwe.
W TinagoDepartment of Community Medicine, FMHS, University of Zimbabwe, Harare, Zimbabwe, School of Medicine, University College Dublin, Dublin, Ireland.
V ChikwashaDepartment of Community Medicine, FMHS, University of Zimbabwe, Harare, Zimbabwe.
M NgwenyaWorld Health Organisation, Harare Country Office, Zimbabwe.
J MutsvangwaBiomedical Research and Training Institute, Harare, Zimbabwe.
J Z MetcalfeDivision of Pulmonary and Critical Care Medicine, Zuckerberg San Francisco General Hospital and Trauma Center, University of California, San Francisco, CA, USA.
C SandyNational TB Control Programme, Ministry of Health and Child Care, Harare, Zimbabwe.

Funding

Training for Research Excellence and MeNtorship in Tuberculosis (TRENT)D43TW009539 · FIC · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI METCALFE, JOHN ZAPATA · 2013 to 2022
$2.9M
FIC NIH HHS D43 TW009539World Health Organization 001
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Mycobacterium tuberculosisTuberculosis, PulmonaryAdolescentAdultAgedCross-Sectional StudiesHumansMalePrevalenceSputumZimbabwe

Identifiers

PMID34969430
PMCPMC8895472

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.